Literature DB >> 8760132

Dynamics of TGF-beta 3 peptide activity during rat alveolar epithelial cell proliferative recovery from acute hyperoxia.

S Buckley1, K C Bui, M Hussain, D Warburton.   

Abstract

Hyperoxia causes a reproducible pattern of lung injury and recovery, characterized by proliferation of type II alveolar epithelial cells (AEC2) during the recovery phase. We measured TGF-beta peptide production by AEC2 and macrophages from lungs of adult male rats exposed to 100% oxygen for 48 h and then allowed to recover for up to 72 h in room air. TGF-beta peptide activity levels were measured using the PAI-1 promoter-luciferase mink lung epithelial cell assay and characterized with peptide specific inhibitory antibodies. Control AEC2 produced 997 +/- 54 pg active TGF-beta x 10(6) cells-1.24h-1 (mean +/- SD), of which > 70% was TGF-beta 3, while cultured macrophages produced 58 +/- 17 pg active TGF-beta x 10(6) macrophages-1.24 h-1, > 80% of which was TGF-beta 1. During hyperoxia and recovery, active TGF-beta 3 production by AEC2 decreased by 75%, with a nadir at 24 h recovery (P < 0.005). In contrast, TGF-beta peptide activity increased from undetectable levels in lung lavage from control rats to a peak of 1,470 +/- 743 pg/rat after 48 h oxygen exposure and 24 h recovery, while lavaged macrophage TGF-beta production in culture also increased threefold to a peak of 150 +/- 5 pg. 10(6) cells-1. 24 h-1 after 48 h oxygen exposure (P < 0.005). The nadir of active TGF-beta 3 production by AEC2 coincided with the peak of the AEC2 proliferative phase of repair as determined by BrdU incorporation and FACS analysis of freshly isolated AEC2. We conclude that active TGF-beta 3 production by AEC2 is dynamically downregulated during the proliferative phase of recovery from acute hyperoxic injury in rat. We speculate that decreased autocrine negative regulation of AEC2 proliferation by TGF-beta 3 may facilitate AEC2 proliferation during recovery from acute hyperoxic injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760132     DOI: 10.1152/ajplung.1996.271.1.L54

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  The milieu of damaged alveolar epithelial type 2 cells stimulates alveolar wound repair by endogenous and exogenous progenitors.

Authors:  Susan Buckley; Wei Shi; Gianni Carraro; Sargis Sedrakyan; Stefano Da Sacco; Barbara A Driscoll; Laura Perin; Roger E De Filippo; David Warburton
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-23       Impact factor: 6.914

2.  Single cell RNA sequencing identifies TGFβ as a key regenerative cue following LPS-induced lung injury.

Authors:  Kent A Riemondy; Nicole L Jansing; Peng Jiang; Elizabeth F Redente; Austin E Gillen; Rui Fu; Alyssa J Miller; Jason R Spence; Anthony N Gerber; Jay R Hesselberth; Rachel L Zemans
Journal:  JCI Insight       Date:  2019-03-26

Review 3.  Alveolar epithelial type II cell: defender of the alveolus revisited.

Authors:  H Fehrenbach
Journal:  Respir Res       Date:  2001-01-15

4.  A crosstalk between type 2 innate lymphoid cells and alternative macrophages in lung development and lung diseases (Review).

Authors:  Lan-Lan Mi; Yue Zhu; Hong-Yan Lu
Journal:  Mol Med Rep       Date:  2021-03-31       Impact factor: 2.952

5.  Phenotypic alterations in type II alveolar epithelial cells in CD4+ T cell mediated lung inflammation.

Authors:  Marcus Gereke; Lothar Gröbe; Silvia Prettin; Michael Kasper; Stefanie Deppenmeier; Achim D Gruber; Richard I Enelow; Jan Buer; Dunja Bruder
Journal:  Respir Res       Date:  2007-07-04

Review 6.  Growth factor signaling in lung morphogenetic centers: automaticity, stereotypy and symmetry.

Authors:  David Warburton; Saverio Bellusci; Pierre-Marie Del Moral; Vesa Kaartinen; Matt Lee; Denise Tefft; Wei Shi
Journal:  Respir Res       Date:  2003-06-19

7.  Hyperoxia promotes polarization of the immune response in ovalbumin-induced airway inflammation, leading to a TH17 cell phenotype.

Authors:  Akinori C Nagato; Frank S Bezerra; André Talvani; Beatriz J Aarestrup; Fernando M Aarestrup
Journal:  Immun Inflamm Dis       Date:  2015-06-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.